Form 4: Director Svetlana Dey Increases Stake in Bluejay Diagnostics

Director Svetlana Dey acquired 12,500 shares of Bluejay Diagnostics, Inc. common stock in a private placement transaction.

Summary

• Director Svetlana Dey purchased 12,500 shares of Bluejay Diagnostics, Inc. (BJDX) common stock.
• The transaction occurred on March 14, 2026, at a price of $2.00 per share.
• Following this acquisition, Ms. Dey holds 12,500 shares directly and maintains indirect ownership of 127 shares through Lana Management & Business Research International, LLC.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it reflects direct financial commitment from a member of the board of directors.

Positives

• Insider confidence is demonstrated by a director purchasing shares directly from the company.
• The purchase price of $2.00 per share indicates management's commitment to the company's valuation.

Negatives

• The transaction volume is relatively small in the context of total outstanding shares.

Risks

• The company is subject to the inherent risks of the diagnostics industry, including regulatory hurdles and market competition.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal of management's belief in the company's long-term prospects, particularly when shares are acquired via private placement directly from the issuer.

Comparison to Industry Standards

• Insider purchases are a standard indicator of alignment between leadership and shareholder interests.
• The use of private placements for director participation is a common mechanism for capital infusion in small-cap biotech and diagnostic firms.

Related Party Transactions

• The reporting person maintains voting and dispositive power over shares held by Lana Management & Business Research International, LLC.

Stakeholder Impact

• Shareholders may interpret this purchase as a sign of stability and confidence from the board.

Next Steps

• Continued monitoring of insider trading activity for further signals of management sentiment.

Key Dates

Recommendation

While insider buying is a positive signal, this specific transaction is small in scale and does not fundamentally alter the investment thesis for the company.

Keywords

Bluejay Diagnostics, BJDX, Insider Trading, Form 4, Director Purchase, Private Placement